Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial

Journal of Clinical Pharmacology
P T LeeseG S Geis

Abstract

Conventional nonsteroidal anti-inflammatory drugs (NSAIDs) nonspecifically inhibit cyclooxygenase-1 (COX-1), an enzyme critical to normal platelet function, and COX-2, which mediates inflammatory response mechanisms. Celecoxib, an antiarthritic agent that inhibits COX-2 but spares COX-1 at therapeutic doses, is expected to have minimal effects on platelet function. A double-blind, randomized, placebo-controlled study of 10 days' duration was conducted in 24 healthy adults to compare the effects on platelet function of a supratherapeutic dose of celecoxib (600 mg bid) with a standard dose of naproxen (500 mg bid), a conventional NSAID. Ex vivo platelet aggregation in response to standard agonists (collagen, arachidonate, or U46619 [a thromboxane A2 receptor agonist]), bleeding time, and serum thromboxane B2 (TxB2) level were measured. Unlike celecoxib or placebo, naproxen produced statistically significant reductions in platelet aggregation and serum TxB2 levels and increased bleeding time. The results indicate that even at supratherapeutic doses, celecoxib will not interfere with normal mechanisms of platelet aggregation and hemostasis, supporting the premise that celecoxib is COX-1 sparing relative to conventional NSAIDs.

References

Jul 12, 1975·Lancet·A E EmeryW M McCrae
Oct 1, 1991·Archives of Internal Medicine·C S Connelly, R S Panush
Jan 1, 1991·Archives of Internal Medicine·G BasheinG A Misbach
Jan 1, 1986·Annual Review of Biochemistry·P NeedlemanJ B Lefkowith
Mar 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D L DeWitt, W L Smith
May 1, 1988·Clinical Pharmacology and Therapeutics·K A ConradP V Mayshar
Jul 27, 1972·The New England Journal of Medicine·L A Harker, S J Slichter
Apr 1, 1974·Journal of Clinical Pharmacology·J NadellE J Segre
Aug 1, 1984·Scandinavian Journal of Haematology·S CronbergI Söderberg
Oct 30, 1982·British Medical Journal·I Stockley
Sep 1, 1981·Clinical Pharmacology and Therapeutics·D GreenC Ts'ao
Feb 1, 1982·American Journal of Surgery·L KitchenH Sideropoulos
Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·K SeibertP C Isakson
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·J L MasferrerK Seibert
Dec 2, 1999·JAMA : the Journal of the American Medical Association·L S SimonG S Geis
Aug 1, 1963·The Journal of Physiology·G V BORN, M J CROSS

Citations

Dec 20, 2005·Der Orthopäde·K J WagnerL Gerdesmeyer
Mar 20, 2009·Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA·Sigbjorn DimmenJan Erik Madsen
Jul 28, 2004·European Journal of Clinical Pharmacology·Deborah LaytonSaad A W Shakir
Dec 8, 2007·International Journal of Colorectal Disease·Anders JakobsenVagn Ove Bendtsen
May 27, 2009·Current Reviews in Musculoskeletal Medicine·J Bryan Dixon
Jan 11, 2001·Pharmacology & Therapeutics·R D MacPherson
Sep 11, 2003·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Donald R MehlischRichard C Hubbard
Mar 22, 2001·Journal of Clinical Anesthesia·C L Wu
Nov 13, 2001·Journal of Clinical Anesthesia·F Jin, F Chung
Feb 11, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Jay L GoldsteinInvestigators
Jul 27, 2004·Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine·Robert PetrellaJ G Fort
Apr 17, 2001·American Journal of Therapeutics·K M VerburgP C Isakson
Apr 15, 2004·Postgraduate Medical Journal·E J Hall, N P Sykes
Jan 25, 2002·Annual Review of Pharmacology and Toxicology·Lawrence J Marnett, Raymond N DuBois
Dec 14, 2011·Hematology·Barbara A Konkle
Jan 14, 2003·Pharmacotherapy·Suphat SubongkotDeborah Drajer
Sep 8, 2000·Journal of the American Veterinary Medical Association·C J Jones, S C Budsberg
Jul 28, 2009·Journal of Neurosurgery·Scott Y RahimiJohn R Vender
Nov 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·M OuelletM D Percival
Oct 2, 2014·International Journal of Oral and Maxillofacial Surgery·Y YamashitaM Goto
Mar 20, 2001·Current Rheumatology Reports·J S Sundy
Feb 16, 2013·European Journal of Orthopaedic Surgery & Traumatology : Orthopédie Traumatologie·Kairui ZhangXiaochun Bai
Jul 26, 2003·QJM : Monthly Journal of the Association of Physicians·E A J Knijff-DutmerM A F J Van de Laar
Feb 1, 2005·Best Practice & Research. Clinical Anaesthesiology·Lynn M Broadman

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Nodding Syndrome

Nodding Syndrome is a neurological and epileptiform disorder characterized by psychomotor, mental, and growth retardation. Discover the latest research on Nodding Syndrome here.

LRRK2 & Microtubules

Mutations in the LRRK2 gene are risk-factors for developing Parkinson’s disease (PD). LRRK2 mutations in PD have been shown to enhance its association with microtubules. Here is the latest research.